Hs.NRAS G12D Citations (2)
Originally described in: RAS mutant collection V2.0Esposito unpublished
Articles Citing Hs.NRAS G12D
| Articles |
|---|
| RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia. Decroocq J, Birsen R, Montersino C, Chaskar P, Mano J, Poulain L, Friedrich C, Alary AS, Guermouche H, Sahal A, Fouquet G, Gotanegre M, Simonetta F, Mouche S, Gestraud P, Lescure A, Del Nery E, Bosc C, Grenier A, Mazed F, Mondesir J, Chapuis N, Ho L, Boughalem A, Lelorc'h M, Gobeaux C, Fontenay M, Recher C, Vey N, Guille A, Birnbaum D, Hermine O, Radford-Weiss I, Tsantoulis P, Collette Y, Castellano R, Sarry JE, Pasmant E, Bouscary D, Kosmider O, Tamburini J. Leukemia. 2022 May;36(5):1237-1252. doi: 10.1038/s41375-022-01541-0. Epub 2022 Mar 30. PubMed |
| Disparate leukemia mutations converge on nuclear phase-separated condensates. Datar GK, Khabusheva E, Anand A, Beale J, Sadek M, Chen CW, Potolitsyna E, Alcantara-Contessoto N, Liu G, De La Fuente J, Dollinger C, Guzman A, Martell A, Wohlan K, Maiti A, Short NJ, Yi SS, Andresen V, Gjertsen BT, Falini B, Rau RE, Brunetti L, Sahni N, Goodell MA, Riback JA. Cell. 2025 Dec 11;188(25):7118-7136.e21. doi: 10.1016/j.cell.2025.10.010. Epub 2025 Nov 4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.